Cigna Group (CI)
(Delayed Data from NYSE)
$341.50 USD
-3.00 (-0.87%)
Updated May 3, 2024 04:00 PM ET
After-Market: $341.43 -0.07 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$341.50 USD
-3.00 (-0.87%)
Updated May 3, 2024 04:00 PM ET
After-Market: $341.43 -0.07 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
5 HMO Stocks Set to Gain From Growing Membership, Tech Advancements
by Debasmita Chatterjee
Rising premiums, contract wins, a telehealth services suite and the M&A strategy are expected to drive the performances of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from encouraging industry prospects.
Cigna (CI) Unit Unveils Pricing Model for Pharmacy Clients
by Zacks Equity Research
Cigna's (CI) sub-unit Express Scripts introduces a pricing option for prescription drugs that may bolster the customer base and fetch higher pharmacy revenues to the health insurer.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pediatrix (MD) Q3 Earnings Miss on High Costs, Shares Down 12%
by Zacks Equity Research
Pediatrix's (MD) third-quarter results suffer from the decline in same-unit revenues attributable to patient volume. Management currently expects 2023 adjusted EBITDA to be within $200-$210 million.
Why Cigna (CI) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cigna (CI) Q3 Earnings Beat on Membership Growth, '23 EPS View Up
by Zacks Equity Research
Cigna's (CI) Q3 results benefit on well-performing U.S. Commercial and Medicare Advantage businesses. Management currently expects 2023 adjusted EPS to be a minimum of $24.75.
Here's What Key Metrics Tell Us About Cigna (CI) Q3 Earnings
by Zacks Equity Research
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cigna (CI) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 1.65% and 2.32%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Cigna (CI) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Evaluate the expected performance of Cigna (CI) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Humana (HUM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 8.81% and 0.63%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Can High Benefits and Expenses Affect Cigna (CI) Q3 Earnings?
by Zacks Equity Research
Cigna's (CI) third-quarter results are likely to reflect growth in medical customers and pharmacy revenues.
Cigna (CI) Stock Moves -0.25%: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $303.89, marking a -0.25% move from the previous day.
Molina (MOH) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 3.70% and 2.94%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Cigna (CI) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Cigna (CI) Fell More Than Broader Market
by Zacks Equity Research
In the closing of the recent trading day, Cigna (CI) stood at $301.05, denoting a -1.87% change from the preceding trading day.
Here's Why Cigna (CI) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Cigna (CI) Dipped More Than Broader Market Today
by Zacks Equity Research
In the most recent trading session, Cigna (CI) closed at $310.60, indicating a -0.49% shift from the previous trading day.
Q3 Earnings Scorecard and Analyst Reports for Walmart, Nike & TJX
by Sheraz Mian
Today's Research Daily features a real-time scorecard of the Q3 earnings season and new research reports on 16 stocks, including Walmart, Nike & TJX.
Here's How Much a $1000 Investment in Cigna Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Cigna (CI) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $294.45, marking a +0.92% move from the previous day.
Cigna's (CI) Evernorth Acquires Bright.md Technology Platform
by Zacks Equity Research
Cigna's (CI) Evernorth arm acquires Bright.md, enhancing MDLIVE's virtual care capabilities.
Cigna's (CI) Evernorth Launches Value-Based Care Program
by Zacks Equity Research
Cigna's (CI) Evernorth arm introduces a measurement-based care program for its behavioral health network.
Why Cigna (CI) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cigna (CI) Unveils 2024 Expansion Plans, Eyes Membership Growth
by Zacks Equity Research
Cigna (CI) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.